BTIG raised the firm’s price target on Apogee Therapeutics (APGE) to $100 from $81 and keeps a Buy rating on the shares. Eli Lilly (LLY) ...

BTIG raised the firm’s price target on Northrop Grumman (NOC) to $600 from $565 and keeps a Buy rating on the shares. The firm expects Defense Systems to grow the fastest through the outyears with the ...

On Thursday, Vuzix Corp (VUZI) stock saw a modest uptick, ending the day at $1.34 which represents a slight increase of $0.03 or 2.29% from the prior close of $1.31. The stock opened at $1.32 and ...

Jonathan Krinsky, BTIG chief market technician, joins 'Squawk Box' to discuss the latest market trends, why he expects a 5% ...

Fintel reports that on October 24, 2024, BTIG downgraded their outlook for Helix Energy Solutions Group (NYSE:HLX) from Buy ...

Helix Energy Solutions drops after mixed Q3 results and downgrade by BTIG Research as broader offshore activity pauses.

On Wednesday, MGM Resorts International (MGM) stock saw a decline, ending the day at $39.64 which represents a decrease of $-0.88 or -2.17% from the prior close of $40.52. The stock opened at $40.28 ...

Nvidia, which importantly commands an S&P 500 weighting of around 7%, touched an intraday high near $144.50 on Tuesday. That breakout to a fresh record was closely-watched says Jonathan Krinsky, chief ...

The October 22 report on Hoka noted signs that the running footwear brand’s multi-year growth is moderating. The firm also ...

Competitors are playing catch-up, BTIG noted, with some signs of market share loss in the specialty running segment over the ...

BTIG analyst sees upside in Affirm stock to $68. The fintech is fully committed to soon becoming a profitable company.

According to Ponzio, there is a wide range of the buy-side’s adoption of algorithms. Some use algorithms, but only manually, and don’t really measure performance, but instead use poor benchmarks like ...